STAGE IIA PROSTATE CANCER
Clinical trials for STAGE IIA PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA PROSTATE CANCER trials appear
Sign up with your email to follow new studies for STAGE IIA PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation cocktail aims to cut prostate cancer treatment time
Disease control OngoingThis early-phase trial tests combining two types of radiation therapy for men with intermediate-risk prostate cancer. First, a small radioactive source is placed inside the prostate for 10-20 minutes (brachytherapy), followed by three weeks of highly focused external radiation (S…
Matched conditions: STAGE IIA PROSTATE CANCER
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 23, 2026 22:20 UTC
-
New radiation approach aims to tame prostate cancer with fewer side effects
Disease control OngoingThis study tests a type of radiation called high-dose brachytherapy for men with prostate cancer that hasn't spread. Doctors place tiny radioactive sources directly into the prostate to deliver a strong dose to the tumor while sparing nearby healthy tissue. The goal is to control…
Matched conditions: STAGE IIA PROSTATE CANCER
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 01, 2026 18:05 UTC
-
New radiation approach aims to safely target returning prostate cancer
Symptom relief OngoingThis early-stage study tests a high-precision radiation treatment called stereotactic body radiation therapy (SBRT) for men whose prostate cancer has returned after surgery. The main goal is to find the safest dose by monitoring side effects in 26 participants. The treatment deli…
Matched conditions: STAGE IIA PROSTATE CANCER
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 18, 2026 11:48 UTC